Literature DB >> 28905562

[Pathomechanisms of podocyte injury in diabetic nephropathy and interventional effects of Chinese herbal medicine].

Ge Shi1, Zhi-Min Mao1, Yi-Gang Wan2, Shan-Mei Shen3, Wei Wu1, Jing-Jing Yang1, Jian Yao4.   

Abstract

Podocyte injury is closely related to proteinuria in the progress of diabetic nephropathy(DN). The pathological characters of podocyte injury mainly refer to the change of podocyte form and function, including foot process effacement, reduction of podocyte number and density, podocyte apoptosis, podocyte epithelial-mesenchymal transdifferentiation(EMT)and podocyte hypertrophy. These pathological damages are controlled by multiple signaling pathways in the kidney, such as mammalian target of rapamycin(mTOR)/autophagy pathway, transforming growth factor(TGF)-β1 pathway and Notch pathway. For podocyte injuries induced by high glucose or in murine models of DN, some Chinese herbal medicine(CHM)extracts, such as multiglycoside of Tripterygium wilfordii(GTW), triptolide(TP), astragaloside IV(AS-IV), astragalus polysaccharide(APS)and Panax notoginseng saponins(PNS), have the protective effects in vivo or in vitro. The preliminary studies in China showed that GTW improves podocyte injury in the DN model rats probably through regulating the activity of mTORC1 signaling pathway in the kidney. Therefore, it is the developmental direction for the further study to clarify the interventional effects of CHM based on podocyte injury-related signaling pathway in DN. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  Chinese herbal medicine ; diabetic nephropathy ; mTOR/autophagy signaling pathway ; pathomechanism ; podocyte

Mesh:

Substances:

Year:  2016        PMID: 28905562     DOI: 10.4268/cjcmm20161308

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Based on network pharmacology to explore the molecular mechanisms of astragalus membranaceus for treating T2 diabetes mellitus.

Authors:  Jie Li; Yanqin Huang; Sen Zhao; Qiuyue Guo; Jie Zhou; Wenjing Han; Yunsheng Xu
Journal:  Ann Transl Med       Date:  2019-11

Review 2.  Recent Advances in Traditional Chinese Medicine for Treatment of Podocyte Injury.

Authors:  Tianwen Yao; Wenxiang Su; Shisheng Han; Yan Lu; Yanqiu Xu; Min Chen; Yi Wang
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

3.  Influence of astragaloside IV on pharmacokinetics of triptolide in rats and its potential mechanism.

Authors:  Jian Gao; Xiangmin Zeng; Wei Zhao; Desheng Chen; Jing Liu; Ning Zhang; Xingliang Duan
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.